88 related articles for article (PubMed ID: 8901006)
1. Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide.
Lizasoain I; Leza JC; Cuéllar B; Moro MA; Lorenzo P
Eur J Pharmacol; 1996 Mar; 299(1-3):41-5. PubMed ID: 8901006
[TBL] [Abstract][Full Text] [Related]
2. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
3. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
7. Correlation between brain nitric oxide synthase activity and opiate withdrawal.
Leza JC; Lizasoain I; Cuéllar B; Moro MA; Lorenzo P
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):349-54. PubMed ID: 8692292
[TBL] [Abstract][Full Text] [Related]
8. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs.
Tanganelli S; Antonelli T; Morari M; Bianchi C; Beani L
Neurosci Lett; 1991 Jan; 122(2):270-2. PubMed ID: 2027527
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
10. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.
González P; Cabello P; Germany A; Norris B; Contreras E
Eur J Pharmacol; 1997 Aug; 332(3):257-62. PubMed ID: 9300257
[TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
[TBL] [Abstract][Full Text] [Related]
12. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
13. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy.
Vaupel DB; Kimes AS; London ED
Eur J Pharmacol; 1997 Apr; 324(1):11-20. PubMed ID: 9137908
[TBL] [Abstract][Full Text] [Related]
14. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
Leal MB; Michelin K; Souza DO; Elisabetsky E
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures.
Grant KA; Snell LD; Rogawski MA; Thurkauf A; Tabakoff B
J Pharmacol Exp Ther; 1992 Mar; 260(3):1017-22. PubMed ID: 1545374
[TBL] [Abstract][Full Text] [Related]
16. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
18. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test.
Ostadhadi S; Ahangari M; Nikoui V; Norouzi-Javidan A; Zolfaghari S; Jazaeri F; Chamanara M; Akbarian R; Dehpour AR
Biomed Pharmacother; 2016 Aug; 82():713-21. PubMed ID: 27470415
[TBL] [Abstract][Full Text] [Related]
20. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
Pałucha A; Brański P; Pilc A
Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
